Steinhart Richard I has filed 75 insider transactions across 3 companies since March 2023.
Most recent transaction: a option exercise of 33 shares of BioXcel Therapeutics, Inc. ($BTAI) on March 14, 2026.
Activity breakdown: 0 open-market purchases and 8 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 14, 2026 | BioXcel Therapeutics, Inc. | $BTAI | Steinhart Richard I | Chief Financial Officer | M | Common Stock | 33 | $0.00 | 6,610.0000 | 14,196,000 | 0.50% | 0.00% |
| March 15, 2026 | BioXcel Therapeutics, Inc. | $BTAI | Steinhart Richard I | Chief Financial Officer | M | Common Stock | 35 | $0.00 | 6,645.0000 | 14,196,000 | 0.53% | 0.00% |
| March 14, 2026 | BioXcel Therapeutics, Inc. | $BTAI | Steinhart Richard I | Chief Financial Officer | M | Restricted Stock Units | 33 | $0.00 | 97.0000 | 14,196,000 | 25.38% | 0.00% |
| March 15, 2026 | BioXcel Therapeutics, Inc. | $BTAI | Steinhart Richard I | Chief Financial Officer | M | Restricted Stock Units | 35 | $0.00 | 247.0000 | 14,196,000 | 12.41% | 0.00% |
| Jan. 1, 2026 | BioXcel Therapeutics, Inc. | $BTAI | Steinhart Richard I | Chief Financial Officer | A | Restricted Stock Units | 70000 | $0.00 | 70,282.0000 | 14,196,000 | 9999.99% | 0.49% |
| Dec. 15, 2025 | BioXcel Therapeutics, Inc. | $BTAI | Steinhart Richard I | Chief Financial Officer | M | Restricted Stock Units | 35 | $0.00 | 282.0000 | 14,196,000 | 11.04% | 0.00% |
| Dec. 14, 2025 | BioXcel Therapeutics, Inc. | $BTAI | Steinhart Richard I | Chief Financial Officer | M | Common Stock | 33 | $0.00 | 6,542.0000 | 14,196,000 | 0.51% | 0.00% |
| Dec. 14, 2025 | BioXcel Therapeutics, Inc. | $BTAI | Steinhart Richard I | Chief Financial Officer | M | Restricted Stock Units | 33 | $0.00 | 130.0000 | 14,196,000 | 20.25% | 0.00% |
| Dec. 15, 2025 | BioXcel Therapeutics, Inc. | $BTAI | Steinhart Richard I | Chief Financial Officer | M | Common Stock | 35 | $0.00 | 6,577.0000 | 14,196,000 | 0.54% | 0.00% |
| Sept. 15, 2025 | BioXcel Therapeutics, Inc. | $BTAI | Steinhart Richard I | Chief Financial Officer | M | Restricted Stock Units | 35 | $0.00 | 317.0000 | 7,843,000 | 9.94% | 0.00% |
| Sept. 14, 2025 | BioXcel Therapeutics, Inc. | $BTAI | Steinhart Richard I | Chief Financial Officer | M | Restricted Stock Units | 33 | $0.00 | 163.0000 | 7,843,000 | 16.84% | 0.00% |
| Sept. 15, 2025 | BioXcel Therapeutics, Inc. | $BTAI | Steinhart Richard I | Chief Financial Officer | M | Common Stock | 35 | $0.00 | 6,509.0000 | 7,843,000 | 0.54% | 0.00% |
| Sept. 14, 2025 | BioXcel Therapeutics, Inc. | $BTAI | Steinhart Richard I | Chief Financial Officer | M | Common Stock | 33 | $0.00 | 6,474.0000 | 7,843,000 | 0.51% | 0.00% |
| Aug. 1, 2025 | BioXcel Therapeutics, Inc. | $BTAI | Steinhart Richard I | Chief Financial Officer | A | Restricted Stock Units | 9000 | $0.00 | 9,000.0000 | 7,843,000 | 9999.99% | 0.11% |
| July 22, 2025 | BioXcel Therapeutics, Inc. | $BTAI | Steinhart Richard I | Chief Financial Officer | A | Common Stock | 4375 | $0.00 | 5,816.0000 | 7,843,000 | 303.61% | 0.06% |
| July 22, 2025 | BioXcel Therapeutics, Inc. | $BTAI | Steinhart Richard I | Chief Financial Officer | M | Restricted Stock Units | 625 | $0.00 | 0.0000 | 7,843,000 | 100.00% | 0.01% |
| July 22, 2025 | BioXcel Therapeutics, Inc. | $BTAI | Steinhart Richard I | Chief Financial Officer | M | Common Stock | 625 | $0.00 | 6,441.0000 | 7,843,000 | 10.75% | 0.01% |
| June 15, 2025 | BioXcel Therapeutics, Inc. | $BTAI | Steinhart Richard I | Chief Financial Officer | M | Common Stock | 35 | $0.00 | 1,441.0000 | 4,834,000 | 2.49% | 0.00% |
| June 14, 2025 | BioXcel Therapeutics, Inc. | $BTAI | Steinhart Richard I | Chief Financial Officer | M | Common Stock | 33 | $0.00 | 1,406.0000 | 4,834,000 | 2.40% | 0.00% |
| June 15, 2025 | BioXcel Therapeutics, Inc. | $BTAI | Steinhart Richard I | Chief Financial Officer | M | Restricted Stock Units | 35 | $0.00 | 352.0000 | 4,834,000 | 9.04% | 0.00% |
| June 14, 2025 | BioXcel Therapeutics, Inc. | $BTAI | Steinhart Richard I | Chief Financial Officer | M | Restricted Stock Units | 33 | $0.00 | 196.0000 | 4,834,000 | 14.41% | 0.00% |
| May 15, 2025 | ATOSSA THERAPEUTICS, INC. | $ATOS | Steinhart Richard I | Not found | A | Stock Option (right to buy) | 125000 | $0.00 | 125,000.0000 | 129,170,004 | 9999.99% | 0.10% |
| March 31, 2025 | Actinium Pharmaceuticals, Inc. | $ATNM | Steinhart Richard I | Director | D | Stock Option (Right to Buy) | 70311 | $0.00 | 0.0000 | 30,070,028 | 100.00% | 0.23% |
| March 31, 2025 | Actinium Pharmaceuticals, Inc. | $ATNM | Steinhart Richard I | Director | D | Stock Option (Right to Buy) | 2500 | $0.00 | 0.0000 | 30,070,028 | 100.00% | 0.01% |
| March 31, 2025 | Actinium Pharmaceuticals, Inc. | $ATNM | Steinhart Richard I | Director | D | Stock Option (Right to Buy) | 2500 | $0.00 | 0.0000 | 30,070,028 | 100.00% | 0.01% |
| March 31, 2025 | Actinium Pharmaceuticals, Inc. | $ATNM | Steinhart Richard I | Director | D | Stock Option (Right to Buy) | 2500 | $0.00 | 0.0000 | 30,070,028 | 100.00% | 0.01% |
| March 31, 2025 | Actinium Pharmaceuticals, Inc. | $ATNM | Steinhart Richard I | Director | D | Stock Option (Right to Buy) | 8333 | $0.00 | 0.0000 | 30,070,028 | 100.00% | 0.03% |
| March 31, 2025 | Actinium Pharmaceuticals, Inc. | $ATNM | Steinhart Richard I | Director | D | Stock Option (Right to Buy) | 8333 | $0.00 | 0.0000 | 30,070,028 | 100.00% | 0.03% |
| March 31, 2025 | Actinium Pharmaceuticals, Inc. | $ATNM | Steinhart Richard I | Director | D | Stock Option (Right to Buy) | 18351 | $0.00 | 0.0000 | 30,070,028 | 100.00% | 0.06% |
| March 31, 2025 | Actinium Pharmaceuticals, Inc. | $ATNM | Steinhart Richard I | Director | D | Stock Option (Right to Buy) | 72156 | $0.00 | 0.0000 | 30,070,028 | 100.00% | 0.24% |
| July 22, 2024 | BioXcel Therapeutics, Inc. | $BTAI | Steinhart Richard I | Chief Financial Officer | A | Stock Option (right to buy) | 1875 | $0.00 | 1,875.0000 | 2,516,000 | 9999.99% | 0.07% |
| July 22, 2024 | BioXcel Therapeutics, Inc. | $BTAI | Steinhart Richard I | Chief Financial Officer | A | Restricted Stock Units | 625 | $0.00 | 625.0000 | 2,516,000 | 9999.99% | 0.02% |
| March 15, 2025 | BioXcel Therapeutics, Inc. | $BTAI | Steinhart Richard I | Chief Financial Officer | M | Common Stock | 34 | $0.00 | 1,373.0000 | 2,535,000 | 2.54% | 0.00% |
| March 15, 2025 | BioXcel Therapeutics, Inc. | $BTAI | Steinhart Richard I | Chief Financial Officer | M | Restricted Stock Units | 34 | $0.00 | 387.0000 | 2,535,000 | 8.08% | 0.00% |
| March 14, 2025 | BioXcel Therapeutics, Inc. | $BTAI | Steinhart Richard I | Chief Financial Officer | M | Common Stock | 31 | $0.00 | 1,339.0000 | 2,535,000 | 2.37% | 0.00% |
| March 14, 2025 | BioXcel Therapeutics, Inc. | $BTAI | Steinhart Richard I | Chief Financial Officer | M | Restricted Stock Units | 31 | $0.00 | 229.0000 | 2,535,000 | 11.92% | 0.00% |
| Jan. 7, 2025 | BioXcel Therapeutics, Inc. | $BTAI | Steinhart Richard I | Chief Financial Officer | A | Stock Option (right to buy) | 270000 | $0.00 | 270,000.0000 | 2,535,000 | 9999.99% | 10.65% |
| Dec. 15, 2024 | BioXcel Therapeutics, Inc. | $BTAI | Steinhart Richard I | Chief Financial Officer | M | Restricted Stock Units | 562 | $0.00 | 5,064.0000 | 2,649,000 | 9.99% | 0.02% |
| Dec. 14, 2024 | BioXcel Therapeutics, Inc. | $BTAI | Steinhart Richard I | Chief Financial Officer | M | Restricted Stock Units | 521 | $0.00 | 2,606.0000 | 2,649,000 | 16.66% | 0.02% |
| Dec. 16, 2024 | BioXcel Therapeutics, Inc. | $BTAI | Steinhart Richard I | Chief Financial Officer | S | Common Stock | 372 | $0.36 | 20,932.0000 | 2,649,000 | 1.75% | 0.01% |
| Dec. 16, 2024 | BioXcel Therapeutics, Inc. | $BTAI | Steinhart Richard I | Chief Financial Officer | S | Common Stock | 205 | $0.36 | 21,157.0000 | 2,649,000 | 0.96% | 0.01% |
| Dec. 15, 2024 | BioXcel Therapeutics, Inc. | $BTAI | Steinhart Richard I | Chief Financial Officer | M | Common Stock | 562 | $0.00 | 21,362.0000 | 2,649,000 | 2.70% | 0.02% |
| Dec. 14, 2024 | BioXcel Therapeutics, Inc. | $BTAI | Steinhart Richard I | Chief Financial Officer | M | Common Stock | 521 | $0.00 | 20,800.0000 | 2,649,000 | 2.57% | 0.02% |
| Sept. 17, 2024 | BioXcel Therapeutics, Inc. | $BTAI | Steinhart Richard I | Chief Financial Officer | A | Common Stock | 21250 | $0.00 | 27,454.0000 | 2,516,000 | 342.52% | 0.84% |
| Oct. 3, 2024 | BioXcel Therapeutics, Inc. | $BTAI | Steinhart Richard I | Chief Financial Officer | S | Common Stock | 7175 | $0.55 | 20,279.0000 | 2,649,000 | 26.13% | 0.27% |
| Sept. 15, 2024 | BioXcel Therapeutics, Inc. | $BTAI | Steinhart Richard I | Chief Financial Officer | M | Common Stock | 563 | $0.00 | 6,560.0000 | 2,516,000 | 9.39% | 0.02% |
| Sept. 16, 2024 | BioXcel Therapeutics, Inc. | $BTAI | Steinhart Richard I | Chief Financial Officer | S | Common Stock | 356 | $0.69 | 6,204.0000 | 2,516,000 | 5.43% | 0.01% |
| Sept. 15, 2024 | BioXcel Therapeutics, Inc. | $BTAI | Steinhart Richard I | Chief Financial Officer | M | Restricted Stock Units | 563 | $0.00 | 5,625.0000 | 2,516,000 | 9.10% | 0.02% |
| Sept. 14, 2024 | BioXcel Therapeutics, Inc. | $BTAI | Steinhart Richard I | Chief Financial Officer | M | Restricted Stock Units | 521 | $0.00 | 3,127.0000 | 2,516,000 | 14.28% | 0.02% |
| Sept. 14, 2024 | BioXcel Therapeutics, Inc. | $BTAI | Steinhart Richard I | Chief Financial Officer | M | Common Stock | 521 | $0.00 | 5,997.0000 | 2,516,000 | 9.51% | 0.02% |
| June 27, 2024 | ATOSSA THERAPEUTICS, INC. | $ATOS | Steinhart Richard I | Not found | A | Stock Option (right to buy) | 125000 | $0.00 | 125,000.0000 | 0 | 9999.99% | 0.00% |
| June 14, 2024 | BioXcel Therapeutics, Inc. | $BTAI | Steinhart Richard I | Chief Financial Officer | M | Common Stock | 521 | $0.00 | 5,286.0000 | 1,929,000 | 10.93% | 0.03% |
| June 15, 2024 | BioXcel Therapeutics, Inc. | $BTAI | Steinhart Richard I | Chief Financial Officer | M | Common Stock | 562 | $0.00 | 5,848.0000 | 1,929,000 | 10.63% | 0.03% |
| June 17, 2024 | BioXcel Therapeutics, Inc. | $BTAI | Steinhart Richard I | Chief Financial Officer | S | Common Stock | 372 | $1.26 | 5,476.0000 | 1,929,000 | 6.36% | 0.02% |
| June 14, 2024 | BioXcel Therapeutics, Inc. | $BTAI | Steinhart Richard I | Chief Financial Officer | M | Restricted Stock Units | 521 | $0.00 | 3,648.0000 | 1,929,000 | 12.50% | 0.03% |
| June 15, 2024 | BioXcel Therapeutics, Inc. | $BTAI | Steinhart Richard I | Chief Financial Officer | M | Restricted Stock Units | 562 | $0.00 | 6,188.0000 | 1,929,000 | 8.33% | 0.03% |
| March 14, 2024 | BioXcel Therapeutics, Inc. | $BTAI | Steinhart Richard I | Chief Financial Officer | M | Restricted Stock Units | 521 | $0.00 | 4,169.0000 | 1,821,000 | 11.11% | 0.03% |
| March 15, 2024 | BioXcel Therapeutics, Inc. | $BTAI | Steinhart Richard I | Chief Financial Officer | M | Restricted Stock Units | 2250 | $0.00 | 6,750.0000 | 1,821,000 | 25.00% | 0.12% |
| March 14, 2024 | BioXcel Therapeutics, Inc. | $BTAI | Steinhart Richard I | Chief Financial Officer | M | Common Stock | 521 | $0.00 | 3,584.0000 | 1,821,000 | 17.01% | 0.03% |
| March 15, 2024 | BioXcel Therapeutics, Inc. | $BTAI | Steinhart Richard I | Chief Financial Officer | M | Common Stock | 2250 | $0.00 | 5,834.0000 | 1,821,000 | 62.78% | 0.12% |
| April 4, 2024 | BioXcel Therapeutics, Inc. | $BTAI | Steinhart Richard I | Chief Financial Officer | S | Common Stock | 1069 | $2.64 | 4,765.0000 | 1,929,000 | 18.32% | 0.06% |
| Dec. 14, 2023 | BioXcel Therapeutics, Inc. | $BTAI | Steinhart Richard I | Chief Financial Officer | M | Common Stock | 521 | $0.00 | 3,063.0000 | 29,268,000 | 20.50% | 0.00% |
| Dec. 14, 2023 | BioXcel Therapeutics, Inc. | $BTAI | Steinhart Richard I | Chief Financial Officer | M | Restricted Stock Units | 521 | $0.00 | 4,690.0000 | 29,268,000 | 10.00% | 0.00% |
| Sept. 14, 2023 | BioXcel Therapeutics, Inc. | $BTAI | Steinhart Richard I | Chief Financial Officer | M | Common Stock | 521 | $0.00 | 2,542.0000 | 29,187,000 | 25.78% | 0.00% |
| Sept. 14, 2023 | BioXcel Therapeutics, Inc. | $BTAI | Steinhart Richard I | Chief Financial Officer | M | Restricted Stock Units | 521 | $0.00 | 5,211.0000 | 29,187,000 | 9.09% | 0.00% |
| June 14, 2023 | BioXcel Therapeutics, Inc. | $BTAI | Steinhart Richard I | Chief Financial Officer | M | Common Stock | 521 | $0.00 | 2,021.0000 | 28,616,000 | 34.73% | 0.00% |
| June 14, 2023 | BioXcel Therapeutics, Inc. | $BTAI | Steinhart Richard I | Chief Financial Officer | M | Restricted Stock Units | 521 | $0.00 | 5,732.0000 | 28,616,000 | 8.33% | 0.00% |
| May 15, 2023 | BioXcel Therapeutics, Inc. | $BTAI | Steinhart Richard I | Chief Financial Officer | S | Common Stock | 5000 | $27.17 | 1,500.0000 | 28,616,000 | 76.92% | 0.02% |
| May 14, 2023 | BioXcel Therapeutics, Inc. | $BTAI | Steinhart Richard I | Chief Financial Officer | M | Restricted Stock Units | 5000 | $0.00 | 0.0000 | 28,616,000 | 100.00% | 0.02% |
| May 14, 2023 | BioXcel Therapeutics, Inc. | $BTAI | Steinhart Richard I | Chief Financial Officer | M | Common Stock | 5000 | $0.00 | 6,500.0000 | 28,616,000 | 333.33% | 0.02% |
| March 14, 2023 | BioXcel Therapeutics, Inc. | $BTAI | Steinhart Richard I | Chief Financial Officer | M | Common Stock | 2084 | $0.00 | 3,584.0000 | 28,015,000 | 138.93% | 0.01% |
| March 15, 2023 | BioXcel Therapeutics, Inc. | $BTAI | Steinhart Richard I | Chief Financial Officer | A | Restricted Stock Units | 9000 | $0.00 | 9,000.0000 | 28,015,000 | 9999.99% | 0.03% |
| March 14, 2023 | BioXcel Therapeutics, Inc. | $BTAI | Steinhart Richard I | Chief Financial Officer | M | Restricted Stock Units | 2084 | $0.00 | 6,253.0000 | 28,015,000 | 25.00% | 0.01% |
| March 15, 2023 | BioXcel Therapeutics, Inc. | $BTAI | Steinhart Richard I | Chief Financial Officer | S | Common Stock | 2084 | $19.50 | 1,500.0000 | 28,015,000 | 58.15% | 0.01% |
| March 15, 2023 | BioXcel Therapeutics, Inc. | $BTAI | Steinhart Richard I | Chief Financial Officer | A | Stock Option (Right to Buy) | 32000 | $0.00 | 32,000.0000 | 28,015,000 | 9999.99% | 0.11% |